期刊文献+

长期口服拉米夫定出现膝关节痛1例 被引量:1

下载PDF
导出
摘要 拉米夫定为合成核苷类药物,可选择性抑制HBV复制,拉米夫定在肝细胞内转化为活性拉米夫定三磷酸酯,竞争性抑制HBV—DNA聚合酶,同时终止DNA链的延长,从而抑制病毒DNA复制,国外应用于治疗艾滋病,国内则应用于慢性乙型肝炎的症状治疗。拉米夫定的不良反应主要有呼吸道感染样症状,头痛、恶心、身体不适、腹痛和腹泻,未报道出现膝关节痛的病例,我院出现1例长期应用拉米夫定出现左膝关节痛的病例。现报道如下:
作者 顾家富
出处 《中原医刊》 2008年第8期67-67,共1页 Central Plains Medical Journal
  • 相关文献

参考文献1

二级参考文献8

  • 1MARION PL, SALAZAR FH, WINTERS MA, etal. Potent efficacy of entecavir (BMS-200475) in a duck model of hepatitis B virus replication [ J]. Antimicrob Agents Chemother, 2002,46 ( 1 ) .. 82-88.
  • 2ONO SK, KATO N, SHIRATORI y, et al. The polymerase L528M mutation cooperates with nucleotide binding-site mutations, increasing hepatitis B virus replication and drug resistance [J]. J Clin Invest, 2001, 107(4) :449-455.
  • 3JULANDER JG, COLONNO RJ, SIDWELL RW, et al. Characterization of antiviral activity of entecavir in transgenic mice expressing hepatitis B virus [J]. Antiviral Res, 2003, 59(3):155-161.
  • 4COLONNO ILI, GENOVESI EV, MEDINA I, et al. Long-term entecavir treaUnent results in sustained antiviral efficacy and prolonged life span in the woodchuck model of chronic hepatitis infection [J].J Infect Dis, 2001, 184(10): 1236-1245.
  • 5de MAN B.A, WOLTERS LM, NEVENS F, etal. Safety and efficacy of oral Entecavir given for 28 days in patients with chronic hepatitis B virus infection [J]. Hepatology, 2001,34(3) :578-582.
  • 6LAI CL, ROSMAWATI M, LAO J, etal. Entecavir is superior to lamivudine in reducing hepatitis B virus DNA in patients with chronic hepatitis B infection [ J ]. Gastroenterology, 2002, 123 ( 6 ) :1831-1838.
  • 7HONKOOP P, de MAN RA. Entecavir: a potent new antiviral drug for hepatitis B [J]. Expert Opin Investig Drugs, 2003,12(4) :683-688.
  • 8YAMANAKA G, WILSON T, INNAIMO S, et al. Metabolic studies on BMS-200475, a new antiviral compound active against hepatitis B virus [J]. Antimicrob Agents Chemother, 1999, 43 ( 1 ) : 190-193.

共引文献53

同被引文献2

引证文献1

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部